Atrium Therapeutics, Inc. RNA
8.72 USD +0.17 (+1.99%)
At closeNov 3, 2026, 4:00 PM EST
8.72 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
8.45 Day range 8.77
7.49 52-week range 16.77
- YTD
- -40.88%
- 1 year
- -40.88%
Financial health
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.3×
FY 2025 5y median -3.3× FY 2025
P/S 13.6×
FY 2025 5y median 13.6× FY 2025
P/B 1.2×
FY 2025 5y median 1.2× FY 2025
P/FCF -5.9×
FY 2025 5y median -5.9× FY 2025
EV/EBITDA 0.2×
FY 2025 5y median 0.2× FY 2025
EV/Sales -0.7×
FY 2025 5y median -0.7× FY 2025
FCF Yield -16.9%
FY 2025 5y median -16.9% FY 2025
Profitability
Gross Margin 100.0%
FY 2025 5y median 100.0% FY 2025
Operating Margin -412.6%
FY 2025 5y median -412.6% FY 2025
Net Margin -411.9%
FY 2025 5y median -411.9% FY 2025
ROE -37.0%
FY 2025 5y median -37.0% FY 2025
ROIC -31.9%
FY 2025 5y median -31.9% FY 2025
ROA -27.5%
FY 2025 5y median -27.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 6.5×
FY 2025 5y median 6.5× FY 2025
Quick Ratio 6.5×
FY 2025 5y median 6.5× FY 2025
Debt / Equity 0.0×
FY 2025 5y median 0.0× FY 2025
Net Debt / EBITDA 3.5×
FY 2025 5y median 3.5× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31